相关实验视频

Updated: Jun 27, 2025

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

对动物和人类数据进行系统审查,比较囊性纤维化和对照之间的鼻潜能差异测试

Cathalijn H C Leenaars¹, Frans R Stafleu², Christine Häger³

¹Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany. Leenaars.Cathalijn@mh-hannover.de.

Scientific reports

|April 26, 2024

概括

鼻腔潜能差异 (nPD) 测试可以有效地识别人类和动物的囊性纤维化 (CF). 然而,不同研究中的不一致的实验方法和结果挑战了它的精度和可重复性.

科学领域:

电子生理学电子生理学
肺部病理学肺部病理学
遗传学是一个遗传学.

背景情况:

鼻腔潜能差异 (nPD) 测试是一种用于诊断囊性纤维化 (CF) 的电生理学方法.
在不同研究中,nPD协议和结果的显著差异引发了对其有效性和准确性的担忧.
本系统性审查涉及人类CF患者和动物模型中nPD测量的可比性.

研究的目的:

为了确定鼻腔潜能差异 (nPD) 在囊性纤维化 (CF) 患者和动物模型中是否受到类似的影响.
评估实验设置变化是否会在人类和动物CF模型中类似地影响nPD测量.

主要方法:

使用PubMed和Embase数据库进行了系统的文献审查.
两位独立审查员选了130项报告CF和对照组体内nPD测量结果的研究.
进行了元分析,以比较基线nPD值,并评估实验变化的影响.

主要成果:

分析证实了CF和人类和动物对照对象之间的不同基线nPD值.
与人类研究相比,动物模型中的基线nPD值通常较低.
在包括的研究中观察到实验设计和结果的显著变化.

结论:

鼻潜在差异 (nPD) 测试是跨物种的囊性纤维化 (CF) 的有效生物标志物.
实验细节的报告不足阻碍了可重现性,需要在CF研究中对nPD测量进行标准化.

关键词:

从动物到人类的翻译囊性纤维化症是什么电子生理学电子生理学鼻腔潜能差异的不同预测值是一个预测值.可复制性可复制性

更多相关视频

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

相关概念视频

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...